Free RAC-US Exam Braindumps
Regulatory Affairs Certification (RAC) US Questions 26–30 (page: 7)

Updated On: 9-Feb-2026

A company is developing a new medical device using innovative technology. Which of the following is MOST critical in working with regulatory authorities?

  1. Documented agreement
  2. Frequent communication
  3. Early collaboration
  4. Follow-up meeting after submission

Answer(s): B



During an audit of a contract manufacturing facility by a potential client, the auditor requested to be left alone in the records room. The records room contains information on all products produced by the contract manufacturer.

Which action is MOST appropriate for the regulatory affairs professional to take?

  1. Allow the auditor access to the room and records due to the current audit.
  2. Allow the auditor accompanied access to the room to retrieve the records.
  3. Deny the auditor access to the room and retrieve only the requested records.
  4. Deny the auditor access to the room and records due to confidentiality concerns.

Answer(s): B



According to ICH, which of the following components of study information is NOT required in a clinical study report?

  1. Randomization scheme and codes
  2. Protocol and protocol amendments
  3. List of lECs or lRBs
  4. Detailed CV of all investigators

Answer(s): D



A global company is developing a sophisticated implantable medical device that is coated with antibiotics and biologics to enhance its efficacy. The product is marketed in Country X. where it is regulated as a medical device. The same product, without the antibiotics and biologics, is marketed as a medical device in Country Y. The company is proposing to start marketing the coated device in Country Y. Which regulatory approach should the company propose?

  1. Submit the product for review as a pharmaceutical product in Country Y.
  2. Submit the product as a medical device in Country Y as the product is already marketed in Country X as a medical device.
  3. Apply for review of the additional part of the product as a pharmaceutical product in Country
  4. Examine decisions made about similar products in Country Y to propose the classification of the product.

Answer(s): C



The intermediate manufacturing process was changed during development of a pharmaceutical. The change may impact the API specification. Which functional area is responsible for the final approval of the change?

  1. Production
  2. Analytical
  3. Quality
  4. Regulatory

Answer(s): C



Viewing page 7 of 21
Viewing questions 31 - 35 out of 100 questions


Post your Comments and Discuss RAPS RAC-US exam prep with other Community members:

AI Tutor AI Tutor 👋 I’m here to help!